These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 19614820

  • 1. Natural killer cell-based immunotherapy in cancer: current insights and future prospects.
    Sutlu T, Alici E.
    J Intern Med; 2009 Aug; 266(2):154-81. PubMed ID: 19614820
    [Abstract] [Full Text] [Related]

  • 2. Prospects for the use of NK cells in immunotherapy of human cancer.
    Ljunggren HG, Malmberg KJ.
    Nat Rev Immunol; 2007 May; 7(5):329-39. PubMed ID: 17438573
    [Abstract] [Full Text] [Related]

  • 3. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J, van de Ven C, Cairo E, Hochberg J, Baxi L, Satwani P, Cairo MS.
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical applications of adoptive natural killer cell immunotherapy for cancer: current status and future prospects.
    Guo H, Qian X.
    Onkologie; 2010 Oct; 33(7):389-95. PubMed ID: 20631487
    [Abstract] [Full Text] [Related]

  • 8. Natural killer cell-based immunotherapeutic strategies.
    Klingemann HG.
    Cytotherapy; 2005 Oct; 7(1):16-22. PubMed ID: 16040380
    [Abstract] [Full Text] [Related]

  • 9. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
    Lim YT, Cho MY, Noh YW, Chung JW, Chung BH.
    Nanotechnology; 2009 Nov 25; 20(47):475102. PubMed ID: 19875875
    [Abstract] [Full Text] [Related]

  • 10. NK cell-based cancer immunotherapy.
    Stagg J, Smyth MJ.
    Drug News Perspect; 2007 Apr 25; 20(3):155-63. PubMed ID: 17520092
    [Abstract] [Full Text] [Related]

  • 11. [Potential role of NK cells in future anti-tumor immunotherapies].
    Iannello A, Débbeche O, Samarani S, Sabbagh S, Duval M, Ahmad A.
    Med Sci (Paris); 2007 May 25; 23(5):502-8. PubMed ID: 17502066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro activation of NK cytotoxicity with IL-2.
    Ibayashi Y, Tokuda Y, Saks ER, Sarna GP, Golub SH.
    Prog Clin Biol Res; 1987 May 25; 244():275-85. PubMed ID: 3498954
    [No Abstract] [Full Text] [Related]

  • 15. Should natural killer cells be expanded in vivo or ex vivo to maximize their therapeutic potential?
    Miller JS.
    Cytotherapy; 2009 May 25; 11(3):259-60. PubMed ID: 19347766
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells.
    Lankester AC, Ball LM, Lang P, Handgretinger R.
    Pediatr Clin North Am; 2010 Feb 25; 57(1):97-121. PubMed ID: 20307714
    [Abstract] [Full Text] [Related]

  • 18. Invariant natural killer T cells and immunotherapy of cancer.
    Molling JW, Moreno M, van der Vliet HJ, van den Eertwegh AJ, Scheper RJ, von Blomberg BM, Bontkes HJ.
    Clin Immunol; 2008 Nov 25; 129(2):182-94. PubMed ID: 18783990
    [Abstract] [Full Text] [Related]

  • 19. Immunologic approaches to acute leukemia in the elderly.
    Farag SS, Caligiuri MA.
    Semin Hematol; 2006 Apr 25; 43(2):118-25. PubMed ID: 16616045
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.